Enteric fever, primarily caused by Salmonella Typhi and Paratyphi, continues to be a significant global health concern. This article presents an updated approach to its diagnosis and treatment, providing a comprehensive guide for healthcare professionals.
The gold standard for diagnosing enteric fever remains blood culture, despite its limitations in sensitivity. Molecular methods, such as Polymerase Chain Reaction (PCR), are emerging as promising tools due to their high sensitivity and specificity. However, these require specialized facilities and trained personnel. Serological tests, like the Widal test, can be useful in resource-limited settings, but their reliability is often questioned due to cross-reactivity.
Antibiotic therapy is the mainstay of treatment for enteric fever. Choice of antibiotic should be guided by local antimicrobial resistance patterns. Fluoroquinolones were once the first-line treatment but rising resistance has necessitated a shift towards third-generation cephalosporins and azithromycin. The role of vaccines in prevention should not be underestimated, especially in endemic areas.
Public health interventions play a crucial role in controlling enteric fever. These include access to clean water, improved sanitation, and food safety measures. In addition, surveillance systems can help monitor disease trends and antimicrobial resistance, guiding policy and practice.
Enteric fever remains a significant public health challenge requiring a multi-faceted approach. While diagnostic methods and treatment strategies continue to evolve, the importance of public health measures in disease control cannot be overstated. As healthcare professionals, staying abreast of these updates is crucial in delivering effective patient care and contributing to global health improvement.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation